BioNexus Gene Lab Corp Common stock (BGLC)vsBHP Group Limited (BHP)
BGLC
BioNexus Gene Lab Corp Common stock
$1.50
-6.83%
BASIC MATERIALS · Cap: $4.72M
BHP
BHP Group Limited
$84.74
-2.77%
BASIC MATERIALS · Cap: $229.80B
Smart Verdict
WallStSmart Research — data-driven comparison
BHP Group Limited generates 1879258% more annual revenue ($58.76B vs $3.13M). BHP leads profitability with a 16.7% profit margin vs -82.4%. BHP earns a higher WallStSmart Score of 57/100 (C).
BGLC
Avoid26
out of 100
Grade: F
BHP
Buy57
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 43.3%
18.3% revenue growth
Generating 7.7B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -35.9% — below average capital efficiency
Revenue declined 96.6%
Weak financial health signals
Expensive relative to growth rate
Earnings declined 9.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : BGLC
The strongest argument for BGLC centers on Price/Book, Debt/Equity, Altman Z-Score.
Bull Case : BHP
The strongest argument for BHP centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 16.7% and operating margin at 43.3%. Revenue growth of 18.3% demonstrates continued momentum.
Bear Case : BGLC
The primary concerns for BGLC are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : BHP
The primary concerns for BHP are Piotroski F-Score, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
BGLC profiles as a turnaround stock while BHP is a growth play — different risk/reward profiles.
BGLC carries more volatility with a beta of 2.21 — expect wider price swings.
BHP is growing revenue faster at 18.3% — sustainability is the question.
BHP generates stronger free cash flow (7.7B), providing more financial flexibility.
Bottom Line
BHP scores higher overall (57/100 vs 26/100), backed by strong 16.7% margins and 18.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BioNexus Gene Lab Corp Common stock
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
BHP Group Limited
BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA
BHP Group engages in the natural resources business in Australia, Europe, China, Japan, India, South Korea, the rest of Asia, North America, South America and internationally. The company is headquartered in Melbourne, Australia.
Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?